2Berger AP, Bartsch G, Deibl M, et al. Atherosclerosis as a risk factor for be- nign prostatic hyperplasia. BJU Int, 2006, 98: 1038-1042.
3Berger AP, Deibl M, Leonhartsberger N, et al. Vascular damage as a risk fac- tor for benign prostatic hyperplasia and erectile dysfunction. BJU Int, 2005, 96: 1073- 1078.
4Berger AP, Kofler K, Bektic J, et al. Increased growth factor prduction in a human prostatic stromal cell culture mdel caused by hypoxia. Prostate, 2003, 57, 57-65.
9Franco OE, Jiang M, Strand DW, et al. Altered TGF-β signaling in a sub- population of human stromal cells pro- motes prostatic carcinogenesis. Cancer Res, 2011, 71: 1272-1281.
3Ghafar MA, Puchner PJ, Anastasiadis AG, et al. Does the prostatic vascular system contribute to the development of benign prostatic hyperplasia? Curr Urol Rep,2002,3: 292-296.
4Berger AP, Bartsch G, Deibl M, et al. Atherosclerosis as a risk factor for benign prostatic hyperplaisa. BJU Int,2006, 98: 1035- 1042.
5Kozlowski R, Kershen RT, Siroky MB, et al. Chronic ischemia alters prostate structure and reactivity in rabbits. J Urol, 2001, 165 : 1019-1026.
6Soulitzis N, Karyotis I, Delakas D, et al. Expression analysis of peptide growth factors VEGF, FGF2, TGFB1, EGF and IGF1 in prostate cancer and benign prostatic hyperplasia. Int J Oncol, 2006, 29 : 305-314.
7Pich A, Ponti R. MIB-1, Ki67 and PCNA scores and flowcytometry in intermediate grade malignant lymphomas. J Clin Pathol, 1994, 47 : 18-22.
8Berger AP, Kofler K, Bektic J, et al. Increased growth factor production in a human prostatic stromal cell culture model caused by hypoxia. Prostate ,2003,57 : 57-65.
9Wendy W, Barclay, Ralph D, et al. A system for studying epithelial-stromal interactions reveals distinct inductive abilities of stromal cells from benign prostatic hyperplasia and prostate cancer. Endocrinology,2005, 146: 13-18.
10Emberton M, Fitzpatrick JM, Garcia-Losa M, et al. Progression of benign prostatic hyperplasia : systematic review of the placebo arms of clinical trials. BJU Int, 2008, 102: 981-956.
